BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance Shares of NASDAQ:BIOL opened at $0.01 on Friday. BIOLASE has a 52 week low of $0.02 and a […]
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance Shares of NASDAQ:BIOL opened at $0.01 on Friday. BIOLASE has a 52 week low of $0.02 and a […]
